口咽鳞状细胞癌根治性治疗中计划质量改进与急性吞咽困难和口干症减轻的相关性
回顾性分析2009年12月至2015年8月根治性治疗的I-IVb期口咽鳞状细胞癌患者,比较SS-IMRT与VMAT的计划质量及急性毒性。共222例,SS-IMRT组134例、VMAT组88例,中位随访时间分别为23.0个月和7.9个月。VMAT组危及器官剂量学终点显著改善,并转化为≥2级急性吞咽困难和口干症发生率显著降低。
要点
- VMAT组危及器官剂量学终点较SS-IMRT组显著改善。
- VMAT组≥2级急性吞咽困难和口干症发生率显著低于SS-IMRT组。
- I-IVb期口咽癌计划质量改进与≥2级急性吞咽困难和口干症减少相关。
核心结论
- I-IVb期口咽癌计划质量的改进与≥2级急性吞咽困难和口干症的发生率降低相关。
研究设计与样本
- 回顾性分析2009年12月至2015年8月根治性治疗的I-IVb期口咽鳞状细胞癌患者的治疗计划。
- 共纳入222例患者,其中134例接受SS-IMRT,88例接受VMAT。
- SS-IMRT组和VMAT组的中位随访时间分别为23.0个月和7.9个月。
主要发现
- VMAT组危及器官的剂量学终点较SS-IMRT组显著改善。
- VMAT组≥2级急性吞咽困难和口干症的发生率显著低于SS-IMRT组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate plan quality using volumetric-modulated arc therapy (VMAT) and step-and-shoot intensity-modulated radiation therapy (SS-IMRT) techniques and for patients treated for oropharyngeal squamous cell carcinoma (OPSCC). METHODS: Treatment plans for patients treated definitively for stages I-IVb, OPSCC between December 2009 and August 2015 were retrospectively reviewed. Dosimetric endpoints of involved organs-at-risk (OARs) were retrieved from clinical plans. Common Terminology Criteria for Adverse Events scores of acute toxicities were compared. RESULTS: Two-hundred twenty-two patients were identified with 134 and 88 receiving SS-IMRT and VMAT with median follow-up time of 23.0 and 7.9 months, respectively. The dosimetric endpoints of the OARs were significantly improved in VMAT cohort, which translated into significantly lower rates of grade 2 or higher acute dysphagia and xerostomia. CONCLUSION: Improvements in stages I-IVb, oropharyngeal cancer plan quality are associated with reduced grade ≥ 2 acute dysphagia and xerostomia.
引用
- Cui T, Ward MC, Joshi NP, et al. Correlation between plan quality improvements and reduced acute dysphagia and xerostomia in the definitive treatment of oropharyngeal squamous cell carcinoma. Head Neck. 2019. PMID: 30702180. doi:10.1002/hed.25594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。